Skip to main content

SUSQUEHANNA ADVISORS GROUP, INC.

Position in PFE — Pfizer Inc

CIK 1444949 BALA CYNWYD, PA

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$144,480,000
+$4,080,000 QoQ
Shares Held
6,000,000
+20.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
5.18%
of 13F equity value
Holder Rank
#81
of 2,812 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$144,480,000
PutShares
6,000,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

SUSQUEHANNA ADVISORS GROUP, INC. holds $144,480,000 across 1 Drug Manufacturers - General name. PFE ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PFE
Pfizer Inc
This page
6,000,000 $144,480,000

All Filings in PFE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $144,480,000 6,000,000
2026-06-30 $144,480,000 6,000,000
2026-03-31 $140,400,000 5,000,000
2026-03-31 $140,400,000 5,000,000
2025-12-31 $169,320,000 6,800,000
2025-12-31 $169,320,000 6,800,000
2025-09-30 $127,400,000 5,000,000
2025-09-30 $127,400,000 5,000,000
2025-06-30 $100,111,200 4,130,000
2025-06-30 $100,111,200 4,130,000
2024-12-31 $92,855,000 3,500,000
2024-12-31 $92,855,000 3,500,000